Wenliang Che Selected Research

MINOCA

3/2024	The correlation of atherogenic index of plasma with non-obstructive CAD and unfavorable prognosis among patients diagnosed with MINOCA.
11/2023	Coronary microvascular dysfunction and myocardial infarction with non-obstructive coronary arteries: Where do we stand?
1/2023	Association of stress hyperglycemia ratio and poor long-term prognosis in patients with myocardial infarction with non-obstructive coronary arteries.
1/2023	Prognostic implication of coronary slow flow assessed by cTFC in patients with myocardial infarction with Non-obstructive coronary arteries.
1/2022	Metabolic syndrome and the risk of adverse cardiovascular events in patients with myocardial infarction with non-obstructive coronary arteries.
1/2022	Combination of White Blood Cell Count to Mean Platelet Volume Ratio and Neutrophil-to-Platelet Ratio Predicts Long-Term Adverse Events in Patients with MINOCA.
1/2022	Association between Initial Serum Total Bilirubin and Clinical Outcome in Myocardial Infarction with Non-Obstructive Coronary Arteries.
1/2021	Low Free Triiodothyronine as a Predictor of Poor Prognosis in Patients With Myocardial Infarction With Non-Obstructive Coronary Arteries.
1/2021	Hyperuricemia Predicts Adverse Outcomes After Myocardial Infarction With Non-obstructive Coronary Arteries.
1/2021	Prognostic Value of GRACE Risk Scores in Patients With Non-ST-Elevation Myocardial Infarction With Non-obstructive Coronary Arteries.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wenliang Che Research Topics

Disease

13	MINOCA 03/2024 - 01/2019
11	Heart Failure 01/2024 - 01/2012
11	Cardiovascular Diseases (Cardiovascular Disease) 04/2023 - 12/2020
6	Stroke (Strokes) 01/2023 - 01/2021
6	Myocardial Infarction 01/2023 - 12/2020
6	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021 - 01/2013
4	Hypertension (High Blood Pressure) 03/2022 - 01/2015
3	Cardiomegaly (Heart Hypertrophy) 05/2015 - 01/2012
2	Hyperglycemia 01/2024 - 01/2023
2	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 10/2023 - 01/2017
2	ST Elevation Myocardial Infarction 03/2022 - 01/2017
2	Acute Coronary Syndrome 02/2022 - 01/2022
2	Death (Near-Death Experience) 01/2022 - 01/2021
2	Hyperuricemia 01/2021 - 01/2021
2	Atrial Fibrillation 01/2019 - 01/2019
2	Hypertrophy 05/2015 - 01/2012
1	Coronary Stenosis (Coronary Artery Stenosis) 03/2024
1	Aortic Valve Stenosis (Aortic Stenosis) 12/2023
1	COVID-19 04/2023
1	Pathologic Constriction (Stenosis) 02/2023
1	Insulin Resistance 01/2023
1	Overweight 01/2022
1	Ischemic Stroke 01/2021
1	Non-ST Elevated Myocardial Infarction 01/2021
1	Diabetes Mellitus 12/2020
1	Heart Diseases (Heart Disease) 01/2019
1	Cardiogenic Shock 01/2017
1	Dyslipidemias (Dyslipidemia) 03/2015
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2015
1	Hypoxia (Hypoxemia) 01/2013
1	Infections 01/2012
1	Left Ventricular Dysfunction 01/2012

Drug/Important Bio-Agent (IBA)

21	omega-Chloroacetophenone (Mace)IBA 03/2024 - 01/2017
5	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2021
3	LDL CholesterolIBA 03/2022 - 03/2015
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2020 - 01/2013
2	Triglycerides (Triacylglycerol)IBA 01/2023 - 03/2015
2	S- (2- chloro- 1,1,2- trifluoroethyl)cysteine (CTFC)IBA 01/2023 - 02/2022
2	HDL CholesterolIBA 03/2022 - 03/2015
2	CholesterolIBA 03/2022 - 12/2020
2	C-Reactive ProteinIBA 02/2022 - 01/2012
2	oxidized low density lipoproteinIBA 01/2019 - 01/2017
2	LipidsIBA 01/2017 - 03/2015
1	Indicators and Reagents (Reagents)IBA 01/2024
1	Apolipoproteins B (ApoB)IBA 10/2023
1	COVID-19 VaccinesIBA 04/2023
1	Antiviral Agents (Antivirals)IBA 04/2023
1	Glucose (Dextrose)FDA LinkGeneric 01/2023
1	CytokinesIBA 02/2022
1	BilirubinIBA 01/2022
1	Uric Acid (Urate)IBA 01/2021
1	Triiodothyronine (Liothyronine)FDA LinkGeneric 01/2021
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2020
1	Clopidogrel (Plavix)FDA Link 12/2020
1	MyoglobinIBA 01/2019
1	MicroRNAs (MicroRNA)IBA 01/2019
1	Messenger RNA (mRNA)IBA 01/2019
1	Circular RNAIBA 01/2019
1	olmesartanIBA 06/2017
1	Angiotensin IIIBA 05/2015
1	Proteins (Proteins, Gene)FDA Link 05/2015
1	LDL Lipoproteins (beta Lipoproteins)IBA 03/2015
1	HDL LipoproteinsIBA 03/2015
1	Endoplasmic Reticulum Chaperone BiPIBA 01/2015
1	lacidipineIBA 01/2015
1	Simvastatin (Zocor)FDA LinkGeneric 01/2013
1	Ezetimibe (Zetia)FDA Link 01/2013
1	Rosuvastatin Calcium (Crestor)FDA Link 01/2013
1	SirtuinsIBA 01/2013
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2012
1	Capsules (Microcapsules)IBA 01/2012
1	pro-brain natriuretic peptide (1-76)IBA 01/2012
1	qiliqiangxinIBA 01/2012

Therapy/Procedure

9	Patient Readmission 11/2023 - 01/2017
3	Secondary Prevention 12/2020 - 01/2019
2	Therapeutics 12/2020 - 06/2017
1	Percutaneous Coronary Intervention 02/2022
1	Ligation 01/2012